iVIGA Tap Fabriksleverandør
These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan
Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 juni. The technology gains life-saving medical insights by analysing human excrement. Virksomheden har indgivet en række af tre patenter, der dækker elementer af dets medicinske toiletsensor.
Three Toilets Detection Health Technologies
The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Europa, Japan og Kina.
A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, OutSenses teknologi kan identificere kilden til blod langs mave-tarmkanalen.
A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.
Ifølge OutSense CEO Yfat Scialom, who predicts that “med eksplosionen af digital medicin, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, inflammatorisk tarmsygdom og urinvejsinfektioner.
Its solution consists of a multispectral optical sensor, en lyskilde og en autonom screeningsenhed, der inkluderer en WiFi-forbindelse. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.
OutSense has developed tools to diagnose abnormalities in human excreta. Oplysninger indhentet fra udtaget blod, kombineret med yderligere analyse af tiden fra blødning til udskillelse, giver detaljer om blødningspatologien. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.
At the beginning of June, OutSense meddelte, at CommuniCare, en stor sundhedsvirksomhed med mere end 90 healthcare facilities in the US, begynder at afprøve sin teknologi i år. Ud over denne pilot, OutSense also plans to conduct clinical trials in Israel and Japan.
Besøg flere nyheder på Viga.cc Nyheder